Back to News
Market Impact: 0.15
InnovAge Prices Secondary Offering Of 10 Mln Shares At $9.25/Shr; Stock Down
Source: Nasdaq
Healthcare & Biotech
InnovAge Holding announced the pricing of a secondary common-stock offering by existing selling stockholders. The article provides no offering size or price; because the shares are being sold by stockholders, the transaction does not indicate direct primary capital proceeds for InnovAge.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
neutral
Sentiment Score
-0.05
More News
- OpenAI’s agent hacked Australia’s Medicare website—the latest rogue AI incident that the company didn’t know about for months
- Australia says OpenAI agent hacked Medicare portal
- US aviation sanctions disrupt Iran flights, push travellers overland
- Meta Debuts $349 Camera-Free Ray-Bans and Brings Muse to Glasses
- OpenAI agents ‘infiltrated Australian government website’
- U.S. demand for Novo Nordisk’s weight loss drugs is so huge that the Danish central bank just doubled the nation’s entire growth forecast